AIM
Axiom Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $577K | Hold |
800
| – | – | 1.5% | 17 |
|
|
2022
Q3 | $551K | Hold |
800
| – | – | 1.1% | 21 |
|
|
2022
Q2 | $473K | Hold |
800
| – | – | 1.36% | 27 |
|
|
2022
Q1 | $559K | Hold |
800
| – | – | 1.22% | 26 |
|
|
2021
Q4 | $505K | Hold |
800
| – | – | 0.49% | 50 |
|
|
2021
Q3 | $484K | Hold |
800
| – | – | 0.49% | 53 |
|
|
2021
Q2 | $447K | Hold |
800
| – | – | 0.35% | 70 |
|
|
2021
Q1 | $379K | Sell |
800
-1,615
| -67% | -$765K | 0.31% | 77 |
|
|
2020
Q4 | $427 | Buy |
2,415
+1,532
| +173% | +$271 | 0.39% | 60 |
|
|
2020
Q3 | $495K | Sell |
883
-100
| -10% | -$56.1K | 0.56% | 47 |
|
|
2020
Q2 | $613K | Sell |
983
-100
| -9% | -$62.4K | 0.81% | 36 |
|
|
2020
Q1 | $529K | Buy |
1,083
+16
| +1% | +$7.82K | 0.94% | 29 |
|
|
2019
Q4 | $400K | Sell |
1,067
-292
| -21% | -$109K | 0.57% | 58 |
|
|
2019
Q3 | $376K | Sell |
1,359
-1,595
| -54% | -$441K | 0.29% | 93 |
|
|
2019
Q2 | $926K | Buy |
2,954
+378
| +15% | +$118K | 0.17% | 148 |
|
|
2019
Q1 | $1.06M | Buy |
2,576
+94
| +4% | +$38.6K | 0.2% | 121 |
|
|
2018
Q4 | $927K | Buy |
+2,482
| New | +$927K | 0.2% | 112 |
|